[Form 4] Longeveron Inc. Insider Trading Activity

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

4

07/17/2025 - 07:45 PM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Longeveron Inc

NASDAQ:LGVN

LGVN Rankings

#5974 Ranked by Market Cap

N/A Ranked by Dividends

LGVN Latest News

Oct 1, 2025

George Paletta, Jr., MD, MBA, Internationally Acclaimed Entrepreneur, Investor and Surgeon, Elected to Longeveron® Board of Directors

Sep 22, 2025

Longeveron® to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa

Sep 3, 2025

Longeveron® Announces Key Leadership Updates

Aug 20, 2025

Longeveron® to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 13, 2025

Longeveron® Announces Second Quarter 2025 Financial Results and Provides Business Update

LGVN Latest SEC Filings

Oct 3, 2025

[Form 4] Longeveron Inc. Insider Trading Activity

Oct 1, 2025

[Form 3] Longeveron Inc. Initial Statement of Beneficial Ownership

Sep 26, 2025

[8-K] Longeveron Inc. Reports Material Event

Sep 19, 2025

[8-K] Longeveron Inc. Reports Material Event

Sep 19, 2025

[8-K] Longeveron Inc. Reports Material Event

LGVN Stock Data

Market Cap 16.12M

Float 16.71M

Insiders Ownership 14.83%

Institutions Ownership 6.96%

Short Percent 5.26%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City MIAMI